SlideShare a Scribd company logo
CASE
PRESENTATION
ARYANA AMIRI
3rd YEAR PHARMD
28/09/2018
• NAME: ABDULMALIK
• AGE:55
• WRIGHT:61KG
• DURATION TIME OF TREATMENT: 7 DAYS
DEFINITION
DCM: dilated cardiomyopathy is condition in which the heart
becomes enlarged and can’t pump blood properly and effectively.
CCF: Heart failure which is also known as congestive cardiac failure
is a condition in which the heart muscle is weakened and can’t
pump as well sit usually does.
DM: it is a metabolic disorder in which blood glucose or blood sugar
is too high.
Etiology
• Coronary artery disease is the most important factor
• Arteries that supply blood to heart muscle, narrow from a build up
of fatty deposits
• Heart attack
• High blood pressure
• Infection of heart muscle by virus or bacteria
• Abnormal heart valves
• Exact cause of heart failure may be unknown
Pathophysiology
Congestive heart failure is a syndrome that can be caused by a variety of
abnormalities, including pressure and volume overload, loss of muscle,
primary muscle disease or excessive peripheral demands such as high
output failure. In the usual form of heart failure, the heart muscle has
reduced contractility. This produces a reduction in cardiac output, which then
becomes inadequate to meet the peripheral demands of the body. The 4
primary determinants of left ventricular (LV) performance are generally
altered as follows: (1) There is an intrinsic decrease in muscle contractility.
(2) Preload or left atrial filling pressure is increased, resulting in pulmonary
congestion and dyspnea. (3) Although systemic blood pressure is often
reduced, there is an increase in systemic vascular resistance (afterload),
which can further reduce cardiac output. (4) Heart rate is generally increased
as part of a compensatory mechanism associated with an increase in
sympathetic tone and circulating catecholamines. In patients with coronary
disease, there is often an imbalance between myocardial oxygen supply and
demand. An increase in heart size may be particularly deleterious by
increasing wall tension because of the Laplace relation and increasing
myocardial oxygen consumption
ALGORITHM
CCF diagnosis
Assess for presence of fluid retention
Fluid retention No fluid retention
ACE inhibitorsDiuretic
Beta blockers
ARB,Spironolactone,digoxin.isosorbide
CURRENT COMPLIANT AND
HISTORY OF PRESENT
ILLNESS• DCM AND CCF
• COUGHING
• BREATHLESSNESS
• JOINT PAIN
• HEADACHE
• NON REGULARLY UNDER MEDICAL
CONTROL
PAST HISTORY
• DCM
PERSONAL HISTORY
• SMOKING
• ALCOHOLISM
• CARBOHYDRATE INTAKE
SOCIAL HISTORY
• DIET—->MIXED (NON-VEG)
• SLEEP—->ADEQUATE
• APPETITE—>NORMAL
PHYSICAL
EXAMINATION
• BP: 130/100 mmHG
• HB: 13 g/dl
• NEUTROPHIL:57%
• LYMPHOCYTE:40%
• MONOCYTE:00%
• PLATELET COUNT: 160000
• PULSE:68/MIN
• S1S2:HEARD CLEARLY
• TEMP:NORMAL
• CNS:NORMAL
PROVISIONAL
DIGANOSIS
• DCM AND CCF
• DM
LABRATOARY DATA
TEST TEST VALUE
NORMAL
VALUE
Hb 13 12-17
WBC 9529 4.5-11K
ESR 22mm/hr 0-29
Blood urea 31mg/dl 15-40mg/dl
DIAGNOSIS TEST
• CHEST X-RAY
• BLOOD SUGAR TEST (155
mg/dl)
MEDICATION TABLE
DRUG NAME DOSE DOSE BEGIN DOSE ENDED
CEFTRIAXONE 1gm 11/09 19/09
T.SPIRONOLACT
ONE
50 mg 11/09 19/09
SERRATIOPEPTID
ASE
10 mg 11/09 19/09
BUDESONIDE 0.5 mg 11/09 19/09
FUROSEMIDE 40mg 11/09 19/09
Metformin 500 mg 11/09 19/09
ASSESSMENT
• DUE TO HIGH BLOOD SUGAR LEVEL DM DIAGNOSED
• ABNORMAL BP CCF AND DCM DIAGNOSED
• MIGRAINE
PATIENT
COUNSELING
• LIMIT SALT AND SUGAR INTAKE
• LOW CARBOHYDRATE DIET
• STOP ALCOHOL AND SMOKING
• TAKING DRUG ON TIME
• RESTRICTION OF SODIUM
THANK YOU ALL

More Related Content

What's hot

Shock Introduction with Management
Shock Introduction with ManagementShock Introduction with Management
Shock Introduction with Management
Anamika Ramawat
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
Roshani Naik
 
Pharmacotherapy of Atherosclerosis
Pharmacotherapy of AtherosclerosisPharmacotherapy of Atherosclerosis
Pharmacotherapy of Atherosclerosis
Koppala RVS Chaitanya
 
Cardiogenic shock (4)
Cardiogenic shock (4)Cardiogenic shock (4)
Cardiogenic shock (4)
medicinaingles1
 
Heart failure
Heart failureHeart failure
Coronary Artery Disease (CAD) from the original author of CAD Tozki
Coronary Artery Disease (CAD) from the original author of CAD TozkiCoronary Artery Disease (CAD) from the original author of CAD Tozki
Coronary Artery Disease (CAD) from the original author of CAD Tozki
Jack Frost
 
Angina pectoris
Angina pectorisAngina pectoris
7. oedema
7. oedema7. oedema
7. oedema
Saugat Chapagain
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
DJ CrissCross
 
3 angina pectoris
3 angina pectoris3 angina pectoris
3 angina pectoris
Chanukya Vanam . Dr
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
V4Veeru25
 
Shock
ShockShock
Shock
OM VERMA
 
Myocardial infraction or Heart attack
Myocardial infraction or Heart attackMyocardial infraction or Heart attack
Myocardial infraction or Heart attack
ANILKUMAR BR
 
Cardiomegaly
CardiomegalyCardiomegaly
Cardiomegaly
OmarAkhtar12
 
markers of cardiac disorders
markers of cardiac disordersmarkers of cardiac disorders
markers of cardiac disorders
AdoniJehuKwari
 
Edema
EdemaEdema
Drugs used in ischaemic heart disease
Drugs used in ischaemic heart diseaseDrugs used in ischaemic heart disease
Drugs used in ischaemic heart disease
Pravin Prasad
 
Classification of haemostatic disorders and shock
Classification of haemostatic disorders and shockClassification of haemostatic disorders and shock
Classification of haemostatic disorders and shock
Urvashi Sodvadiya
 
Shock
Shock Shock
Shock
Abdul Waris
 
Circulatory shock
Circulatory shockCirculatory shock
Circulatory shock
Maria Rina
 

What's hot (20)

Shock Introduction with Management
Shock Introduction with ManagementShock Introduction with Management
Shock Introduction with Management
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
 
Pharmacotherapy of Atherosclerosis
Pharmacotherapy of AtherosclerosisPharmacotherapy of Atherosclerosis
Pharmacotherapy of Atherosclerosis
 
Cardiogenic shock (4)
Cardiogenic shock (4)Cardiogenic shock (4)
Cardiogenic shock (4)
 
Heart failure
Heart failureHeart failure
Heart failure
 
Coronary Artery Disease (CAD) from the original author of CAD Tozki
Coronary Artery Disease (CAD) from the original author of CAD TozkiCoronary Artery Disease (CAD) from the original author of CAD Tozki
Coronary Artery Disease (CAD) from the original author of CAD Tozki
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
7. oedema
7. oedema7. oedema
7. oedema
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
 
3 angina pectoris
3 angina pectoris3 angina pectoris
3 angina pectoris
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
 
Shock
ShockShock
Shock
 
Myocardial infraction or Heart attack
Myocardial infraction or Heart attackMyocardial infraction or Heart attack
Myocardial infraction or Heart attack
 
Cardiomegaly
CardiomegalyCardiomegaly
Cardiomegaly
 
markers of cardiac disorders
markers of cardiac disordersmarkers of cardiac disorders
markers of cardiac disorders
 
Edema
EdemaEdema
Edema
 
Drugs used in ischaemic heart disease
Drugs used in ischaemic heart diseaseDrugs used in ischaemic heart disease
Drugs used in ischaemic heart disease
 
Classification of haemostatic disorders and shock
Classification of haemostatic disorders and shockClassification of haemostatic disorders and shock
Classification of haemostatic disorders and shock
 
Shock
Shock Shock
Shock
 
Circulatory shock
Circulatory shockCirculatory shock
Circulatory shock
 

Similar to therapeutic case

D.cardiomyopathy
D.cardiomyopathyD.cardiomyopathy
D.cardiomyopathy
DIVYA00001
 
Coronary artery disease slide
Coronary artery disease slideCoronary artery disease slide
Coronary artery disease slide
82657885
 
Heart failure
Heart failure Heart failure
Heart failure
Shany Thomas
 
Cardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic diseaseCardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic disease
Anil Khatri
 
Cardiomyopathy
Cardiomyopathy Cardiomyopathy
Cardiomyopathy
Chinna Chadayan
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Diana Lobo
 
cardiacarrest-new.pptx
cardiacarrest-new.pptxcardiacarrest-new.pptx
cardiacarrest-new.pptx
shafina27
 
congestiveheart-131005000245-phpapp01.pdf
congestiveheart-131005000245-phpapp01.pdfcongestiveheart-131005000245-phpapp01.pdf
congestiveheart-131005000245-phpapp01.pdf
MohammadBakari
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
Manjusha Kondepudi
 
Ccf
CcfCcf
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptxCAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
venbarani
 
Myocardial Infarction
Myocardial InfarctionMyocardial Infarction
Myocardial Infarction
Muhammad Adeel
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef Siddiqui
Lateef Siddiqui
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef Siddiqui
Lateef Siddiqui
 
Heart failure
Heart failureHeart failure
Heart failure
kajal sansoya
 
seminar ON cardiomegaly FOR NURSING STUDENTS.pptx
seminar ON cardiomegaly FOR NURSING STUDENTS.pptxseminar ON cardiomegaly FOR NURSING STUDENTS.pptx
seminar ON cardiomegaly FOR NURSING STUDENTS.pptx
Apurva Dwivedi
 
Cardiovascular emergencies - solo.pptx
Cardiovascular emergencies - solo.pptxCardiovascular emergencies - solo.pptx
Cardiovascular emergencies - solo.pptx
AbdulHamidIdris1
 
heartfailure-190730143120.pdf
heartfailure-190730143120.pdfheartfailure-190730143120.pdf
heartfailure-190730143120.pdf
JeenaRaj10
 
Heart failure
Heart failureHeart failure
Heart failure
Kamalesh Lenka
 
CHF (Congestive Heart Failure)
CHF (Congestive Heart Failure)CHF (Congestive Heart Failure)
CHF (Congestive Heart Failure)
Saint Mary's University Philippines
 

Similar to therapeutic case (20)

D.cardiomyopathy
D.cardiomyopathyD.cardiomyopathy
D.cardiomyopathy
 
Coronary artery disease slide
Coronary artery disease slideCoronary artery disease slide
Coronary artery disease slide
 
Heart failure
Heart failure Heart failure
Heart failure
 
Cardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic diseaseCardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic disease
 
Cardiomyopathy
Cardiomyopathy Cardiomyopathy
Cardiomyopathy
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
cardiacarrest-new.pptx
cardiacarrest-new.pptxcardiacarrest-new.pptx
cardiacarrest-new.pptx
 
congestiveheart-131005000245-phpapp01.pdf
congestiveheart-131005000245-phpapp01.pdfcongestiveheart-131005000245-phpapp01.pdf
congestiveheart-131005000245-phpapp01.pdf
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Ccf
CcfCcf
Ccf
 
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptxCAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
CAD,_MI,_ANGINA,_CARDIOMYOPATHY[1] ppt.pptx
 
Myocardial Infarction
Myocardial InfarctionMyocardial Infarction
Myocardial Infarction
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef Siddiqui
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef Siddiqui
 
Heart failure
Heart failureHeart failure
Heart failure
 
seminar ON cardiomegaly FOR NURSING STUDENTS.pptx
seminar ON cardiomegaly FOR NURSING STUDENTS.pptxseminar ON cardiomegaly FOR NURSING STUDENTS.pptx
seminar ON cardiomegaly FOR NURSING STUDENTS.pptx
 
Cardiovascular emergencies - solo.pptx
Cardiovascular emergencies - solo.pptxCardiovascular emergencies - solo.pptx
Cardiovascular emergencies - solo.pptx
 
heartfailure-190730143120.pdf
heartfailure-190730143120.pdfheartfailure-190730143120.pdf
heartfailure-190730143120.pdf
 
Heart failure
Heart failureHeart failure
Heart failure
 
CHF (Congestive Heart Failure)
CHF (Congestive Heart Failure)CHF (Congestive Heart Failure)
CHF (Congestive Heart Failure)
 

Recently uploaded

Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
European Sustainable Phosphorus Platform
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
yqqaatn0
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
AbdullaAlAsif1
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
RASHMI M G
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Equivariant neural networks and representation theory
Equivariant neural networks and representation theoryEquivariant neural networks and representation theory
Equivariant neural networks and representation theory
Daniel Tubbenhauer
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
Applied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdfApplied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdf
University of Hertfordshire
 

Recently uploaded (20)

Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Equivariant neural networks and representation theory
Equivariant neural networks and representation theoryEquivariant neural networks and representation theory
Equivariant neural networks and representation theory
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
Applied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdfApplied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdf
 

therapeutic case

  • 2. • NAME: ABDULMALIK • AGE:55 • WRIGHT:61KG • DURATION TIME OF TREATMENT: 7 DAYS
  • 3. DEFINITION DCM: dilated cardiomyopathy is condition in which the heart becomes enlarged and can’t pump blood properly and effectively. CCF: Heart failure which is also known as congestive cardiac failure is a condition in which the heart muscle is weakened and can’t pump as well sit usually does. DM: it is a metabolic disorder in which blood glucose or blood sugar is too high.
  • 4. Etiology • Coronary artery disease is the most important factor • Arteries that supply blood to heart muscle, narrow from a build up of fatty deposits • Heart attack • High blood pressure • Infection of heart muscle by virus or bacteria • Abnormal heart valves • Exact cause of heart failure may be unknown
  • 5. Pathophysiology Congestive heart failure is a syndrome that can be caused by a variety of abnormalities, including pressure and volume overload, loss of muscle, primary muscle disease or excessive peripheral demands such as high output failure. In the usual form of heart failure, the heart muscle has reduced contractility. This produces a reduction in cardiac output, which then becomes inadequate to meet the peripheral demands of the body. The 4 primary determinants of left ventricular (LV) performance are generally altered as follows: (1) There is an intrinsic decrease in muscle contractility. (2) Preload or left atrial filling pressure is increased, resulting in pulmonary congestion and dyspnea. (3) Although systemic blood pressure is often reduced, there is an increase in systemic vascular resistance (afterload), which can further reduce cardiac output. (4) Heart rate is generally increased as part of a compensatory mechanism associated with an increase in sympathetic tone and circulating catecholamines. In patients with coronary disease, there is often an imbalance between myocardial oxygen supply and demand. An increase in heart size may be particularly deleterious by increasing wall tension because of the Laplace relation and increasing myocardial oxygen consumption
  • 6. ALGORITHM CCF diagnosis Assess for presence of fluid retention Fluid retention No fluid retention ACE inhibitorsDiuretic Beta blockers ARB,Spironolactone,digoxin.isosorbide
  • 7.
  • 8. CURRENT COMPLIANT AND HISTORY OF PRESENT ILLNESS• DCM AND CCF • COUGHING • BREATHLESSNESS • JOINT PAIN • HEADACHE • NON REGULARLY UNDER MEDICAL CONTROL
  • 10. PERSONAL HISTORY • SMOKING • ALCOHOLISM • CARBOHYDRATE INTAKE
  • 11. SOCIAL HISTORY • DIET—->MIXED (NON-VEG) • SLEEP—->ADEQUATE • APPETITE—>NORMAL
  • 12. PHYSICAL EXAMINATION • BP: 130/100 mmHG • HB: 13 g/dl • NEUTROPHIL:57% • LYMPHOCYTE:40% • MONOCYTE:00% • PLATELET COUNT: 160000 • PULSE:68/MIN • S1S2:HEARD CLEARLY • TEMP:NORMAL • CNS:NORMAL
  • 14. LABRATOARY DATA TEST TEST VALUE NORMAL VALUE Hb 13 12-17 WBC 9529 4.5-11K ESR 22mm/hr 0-29 Blood urea 31mg/dl 15-40mg/dl
  • 15. DIAGNOSIS TEST • CHEST X-RAY • BLOOD SUGAR TEST (155 mg/dl)
  • 16. MEDICATION TABLE DRUG NAME DOSE DOSE BEGIN DOSE ENDED CEFTRIAXONE 1gm 11/09 19/09 T.SPIRONOLACT ONE 50 mg 11/09 19/09 SERRATIOPEPTID ASE 10 mg 11/09 19/09 BUDESONIDE 0.5 mg 11/09 19/09 FUROSEMIDE 40mg 11/09 19/09 Metformin 500 mg 11/09 19/09
  • 17. ASSESSMENT • DUE TO HIGH BLOOD SUGAR LEVEL DM DIAGNOSED • ABNORMAL BP CCF AND DCM DIAGNOSED • MIGRAINE
  • 18. PATIENT COUNSELING • LIMIT SALT AND SUGAR INTAKE • LOW CARBOHYDRATE DIET • STOP ALCOHOL AND SMOKING • TAKING DRUG ON TIME • RESTRICTION OF SODIUM